These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 398298)

  • 1. Gastric carcinoma associated with severe hypoglycemia sensitive to diazoxide.
    Tamburrano G; Tamburrano S; Natoli C; Di Mario U; Andreani D
    Diabete Metab; 1979 Dec; 5(4):287-91. PubMed ID: 398298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
    Schikman CH; Chertow BS; Fariss BL
    Acta Paediatr Scand; 1978 Sep; 67(5):671-6. PubMed ID: 358739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazoxide in the management of hypoglycemia in infancy and childhood.
    Ehrlich RM; Martin JM
    Am J Dis Child; 1969 Apr; 117(4):411-6. PubMed ID: 5773408
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in a patient with retroperitoneal sarcoma associated with severe hypoglycemia.
    Tucker WR; Ryan WG; Martin BF; Schwartz TB
    Ann N Y Acad Sci; 1968 Apr; 150(2):395-405. PubMed ID: 5243881
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma insulin and blood glucose during long-term treatment with diazoxide for infant hypoglycemia.
    Victorin LH; Thorell JI
    Acta Paediatr Scand; 1974 Mar; 63(2):302-6. PubMed ID: 4820599
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic leucine-sensitive hypoglycemia syndrome: insulin and glucagon responses and effects of diazoxide.
    Roe TF; Kogut MD
    Pediatr Res; 1982 Jan; 16(1):1-4. PubMed ID: 7041064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
    Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.
    Steinke J; Soeldner JS
    Ann N Y Acad Sci; 1968 Apr; 150(2):326-36. PubMed ID: 4299223
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactive hypoglycaemia in association with disordered islet function and abnormal hepatic glucose-6-phosphatase activity: response to diazoxide.
    Pears J; Jung RT; Browning MC; Taylor R; Burchell A
    Diabet Med; 1991 Apr; 8(3):268-71. PubMed ID: 1646698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration of hypoglycemia].
    Luyckx A; Lefebvre P
    Rev Med Liege; 1974 Apr; 29(8):227-33. PubMed ID: 4363631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of insulin secretion in 2 patients with organic hyperinsulinic hypoglycemia during treatment with diazoxide].
    Linquette M; Fossati P; Fourlinnie JC; Racadot A; May JP; Cappoen JP
    Diabete; 1972; 20(2):87-95. PubMed ID: 5086122
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spontaneous hypoglycemia and chronic kidney insufficiency].
    Langlois M; Robert G; Nawar T; Caron C
    Can Med Assoc J; 1978 May; 118(9):1083-6. PubMed ID: 647592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypoglycemia in children by diazoxide and immunoreactive insulin depressive action].
    Ota M; Takeuchi K; Hibi I; Odawara M
    Horumon To Rinsho; 1970 Apr; 18(4):319-26. PubMed ID: 5464725
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of insulin-secreting tumor successfully treated with diazoxide.
    Takeda H; Watanabe K; Suzuki D; Miyano R; Tanaka K; Machimura H; Yagame M; Inoue W; Kaneshige H; Sakai H
    Tokai J Exp Clin Med; 1991 Mar; 16(1):73-6. PubMed ID: 1780909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide.
    Johnson SF; Schade DS; Peake GT
    Am J Med; 1977 Nov; 63(5):799-804. PubMed ID: 930951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketotic (idiopathic glucagon unresponsive) hypoglycaemia: diazoxide effects.
    Rosenbloom AL
    Arch Dis Child; 1972 Aug; 47(254):544-9. PubMed ID: 5046771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apropos of a case of severe hypoglycemia. Present possibilities of diagnosis and treatment].
    Fontaine R; Schneegans E; Haarscher A; Levy-Silagy J; Hasselmann JL; Meyer-Lutz ; Dorner M
    Ann Pediatr (Paris); 1968 Oct; 15(10):664-70. PubMed ID: 4304698
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and physiologic studies using diazoxide in the treatment of hypoglycemia.
    Field JB; Boyle C; Remer A; Drapanas T
    Ann N Y Acad Sci; 1968 Apr; 150(2):415-28. PubMed ID: 4299227
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia.
    Mehta A; Wootton R; Cheng KN; Penfold P; Halliday D; Stacey TE
    Arch Dis Child; 1987 Sep; 62(9):924-30. PubMed ID: 3314727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.